Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
33.43
-0.85 (-2.48%)
Apr 19, 2024, 4:30 PM EDT - Market closed

Belite Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
6.823.952.382.06
Research & Development
24.848.877.423.69
Operating Expenses
31.6712.829.85.74
Operating Income
-31.67-12.82-9.8-5.74
Interest Expense / Income
0.030.0200.02
Other Expense / Income
-0.07-0.19-0.13-0.01
Pretax Income
-31.62-12.65-9.67-5.75
Income Tax
0.01000
Net Income
-31.63-12.65-9.67-5.75
Shares Outstanding (Basic)
2720109
Shares Outstanding (Diluted)
2720109
Shares Change
33.12%108.74%8.87%-
EPS (Basic)
-1.19-0.63-1.01-0.65
EPS (Diluted)
-1.19-0.63-1.01-0.65
Free Cash Flow
-29.9-11.85-7.53-4.46
Free Cash Flow Per Share
-1.12-0.59-0.79-0.51
EBITDA
-31.2-12.43-9.64-5.71
Depreciation & Amortization
0.40.20.030.02
EBIT
-31.6-12.63-9.67-5.73
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).